MedMira Inc. (MIR.V)
| Previous Close | 0.0950 |
| Open | 0.0900 |
| Bid | 0.0900 x 0 |
| Ask | 0.0950 x 0 |
| Day's Range | 0.0900 - 0.0950 |
| 52 Week Range | 0.0700 - 0.1400 |
| Volume | |
| Avg. Volume | 46,632 |
| Market Cap | 63.156M |
| Beta (5Y Monthly) | 11.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
MedMira Announces the Hire of Vice President of Business Development
HALIFAX, NS / ACCESSWIRE / April 30, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development. Ms. Bell ...
- ACCESSWIRE
MedMira Reports Second Quarter Results FY2024
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 ...
- ACCESSWIRE
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number ...
